Hydrocortisone plus Fludrocortisone for Adults with Septic ShockDjillali Annane, Éric Bellissant, Alain Renault et al.|New England Journal of Medicine|2018Cited by 894
Hydrocortisone in Severe Community-Acquired PneumoniaPierre‐François Dequin, Amélie Le Gouge, Ferhat Meziani et al.|New England Journal of Medicine|2023Cited by 438
Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trialJ. P. Frat, Mohammed Laissy, Jean-Damien Ricard et al.|The Lancet Respiratory Medicine|2019Cited by 176
CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trialPierre‐François Laterre, Bruno François, Gwenhaël Colin et al.|The Lancet Infectious Diseases|2019Cited by 59
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trialNicholas Heming, LEROY Olivier, Alain Renault et al.|The Lancet Respiratory Medicine|2024Cited by 48